Why Axogen Inc (NASDAQ: AXGN) Stock Should Not Be Taken For Granted By Investors In 2025

IPW

In today’s recent session, 0.43 million shares of the Axogen Inc (NASDAQ:AXGN) have been traded, and its beta is 1.00. Most recently the company’s share price was $19.12, and it changed around $0.97 or 5.34% from the last close, which brings the market valuation of the company to $847.85M. AXGN at last check was trading at a discount to its 52-week high of $21.00, offering almost -9.83% off that amount. The share price’s 52-week low was $5.55, which indicates that the recent value has risen by an impressive 70.97% since then. We note from Axogen Inc’s average daily trading volume that its 10-day average is 0.43 million shares, with the 3-month average coming to 532.14K.

Axogen Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.12. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended AXGN as a Hold, whereas 5 deemed it a Buy, and 0 rated it as Underweight. Axogen Inc is expected to report earnings per share of 0.02 for the current quarter.

Axogen Inc (NASDAQ:AXGN) trade information

Instantly AXGN has been showing a green trend so far today with a performance of 5.34% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 19.30 on recent trading dayincreased the stock’s daily price by 0.93%. The company’s shares are currently up 16.02% year-to-date, but still up 8.45% over the last five days. On the other hand, Axogen Inc (NASDAQ:AXGN) is 6.16% up in the 30-day period. We can see from the shorts that 1.85 million shares have been sold at a short interest cover period of 3.87 day(s).

Axogen Inc (AXGN) estimates and forecasts

The year-over-year growth rate is expected to be 15.71%, up from the previous year.

Consensus estimates provided by 7 financial analysts predict the company will bring in an average of 48.76M in revenue for the current quarter. 7 analysts expect Axogen Inc to make 53.4M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 41.38M and 47.91M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 17.84%. Forecasts for the next quarter put sales growth at 11.46%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 21.24%. Axogen Inc earnings are expected to increase by 115.62% in 2025, but the outlook is positive 77.74% per year for the next five years.

Axogen Inc (NASDAQ:AXGN)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 5.50% of Axogen Inc shares, and 81.99% of them are in the hands of institutional investors. The stock currently has a share float of 86.75%. Axogen Inc stock is held by 233.0 institutions, with ARROWMARK COLORADO HOLDINGS LLC being the largest institutional investor. By 2024-06-30, it held 11.7048% of the shares, which is about 5.12 million shares worth $37.04 million.

FIRST LIGHT ASSET MANAGEMENT, LLC, with 7.6499% or 3.34 million shares worth $24.21 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024. The former held 1.31 shares worth $24.98 million, making up 2.95% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 1.16 shares worth around $22.04 million, which represents about 2.61% of the total shares outstanding.